STOCK TITAN

Algorhythm Holdings Inc Form 4 Filings

RIME NASDAQ

Every Form 4 that Algorhythm Holdings Inc (RIME) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RIME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RIME filings page.

Rhea-AI Summary

Algorhythm Holdings, Inc. CFO & General Counsel Andre Alex updated his equity compensation through cancellations and a new stock option grant. A previously granted restricted stock award for 23,818 common shares and a non-qualified stock option for 23,818 shares at $2.78 per share were cancelled and returned to the issuer. In exchange, he received a new non-qualified stock option for 47,636 common shares at an exercise price of $0.76 per share under the 2022 Equity Incentive Plan, with vesting over time. Following these transactions he held no common stock directly and 209,973 stock options in total, reflecting a restructuring of his awards rather than any open-market buying or selling.

Rhea-AI Summary

Algorhythm Holdings, Inc. director Thorn Scott received new equity compensation in the form of stock options and restricted stock. On the grant date, he was awarded a non-qualified stock option covering 39,063 shares of common stock at an exercise price of $1.28 per share, expiring on November 20, 2035. These options vest and become exercisable in equal quarterly installments over one year. He also received a restricted stock award for 19,532 shares of common stock, which likewise vests in equal quarterly installments over one year. Both awards were granted under the company’s 2022 Equity Incentive Plan and represent compensation grants, not open-market purchases or sales.

Rhea-AI Summary

Algorhythm Holdings, Inc. director Bernardo Melo reported receiving new equity awards as part of his compensation. He was granted a restricted stock award covering 19,532 shares of common stock under the company’s 2022 Equity Incentive Plan, which vests in equal quarterly installments over one year from the grant date.

He was also granted a non-qualified stock option to purchase 39,063 shares of common stock at an exercise price of $1.28 per share, expiring in 2035. These options vest and become exercisable in equal quarterly installments over one year, and there were no open-market purchases or sales reported.

Rhea-AI Summary

Algorhythm Holdings, Inc. director Harvey Judkowitz received equity compensation in the form of stock and options. He was granted a restricted stock award covering 19,532 shares of common stock and a non-qualified stock option for 19,532 shares at an exercise price of $1.28 per share.

Both the restricted stock award and the option were granted under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Each award vests in equal quarterly installments over one year from the grant date, meaning the director earns the rights to these shares gradually as service-based conditions are met.

Rhea-AI Summary

ATKINSON GARY KEVIN reported acquisition or exercise transactions in this Form 4 filing.

Algorhythm Holdings, Inc. reported that Chief Executive Officer Gary Kevin Atkinson received a grant of a non-qualified stock option covering 740,597 shares of the company’s common stock. The option was awarded by the board under his amended and restated employment agreement dated February 23, 2026.

The non-qualified stock option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. The shares subject to this option vest and become exercisable in equal quarterly installments over four years starting on February 23, 2026, tying the award to the CEO’s continued service over that period.

Rhea-AI Summary

Andre Alex reported acquisition or exercise transactions in this Form 4 filing.

Algorhythm Holdings, Inc. reported that its CFO & General Counsel, Andre Alex, received a grant of a non-qualified stock option covering 233,791 shares of common stock. The option was granted by the Board under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan and was awarded at no cash cost to him on the grant date. These options vest and become exercisable in equal quarterly installments over four years, beginning on February 23, 2026, tying the award to continued service over the long term.

Rhea-AI Summary

Kapoor Ajesh reported acquisition or exercise transactions in this Form 4 filing.

Algorhythm Holdings, Inc. director Ajesh Kapoor reported an equity award of 128,762 shares of common stock. The shares were granted on February 23, 2026 at a stated price of $0.00 per share, bringing his directly held total to 128,762 shares following the grant.

The Board of Directors granted the award under Kapoor’s Amended and Restated Employment Agreement with SemicCab Holdings, LLC, a subsidiary of Algorhythm Holdings, Inc., pursuant to the company’s 2022 Equity Incentive Plan.